News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Derakhshan Behrad
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/18/2023 |
4
| Derakhshan Behrad (Chief Business Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 220,000 options to buy
@ $7.08, valued at
$1.6M
|
|
| 05/03/2023 |
4
| Derakhshan Behrad (Chief Business Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Sold 1,747 shares
@ $8.9049, valued at
$15.6k
Exercised 5,208 restricted stock units
@ $0 |
|
| 08/10/2022 |
4
| Derakhshan Behrad (Chief Business Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 200,000 options to buy
@ $10.39, valued at
$2.1M
|
|
| 05/03/2022 |
4
| Derakhshan Behrad (Chief Business Officer) has filed a Form 4 on Edgewise Therapeutics, Inc.|
Txns:
| Granted 15,625 restricted stock units
@ $0 |
|
| 08/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/25/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|